atorvastatin has been researched along with Infections, Coronavirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, CW; Friedman, HJ; Rodriguez-Nava, G; Trelles-Garcia, DP; Trelles-Garcia, VP; Yanez-Bello, MA | 1 |
| Bhati, S; Bhatnagar, S; Bhushan, S; Deepti, S; Dwivedi, T; Garg, R; Ghati, N; Guleria, R; Gupta, R; Mahendran, M; Mani, K; Mohan, A; Roy, A; Saxena, A; Thakur, A; Tiwari, P | 1 |
1 trial(s) available for atorvastatin and Infections, Coronavirus
| Article | Year |
|---|---|
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Topics: Adult; Aged; Aspirin; Atorvastatin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Host-Pathogen Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Male; Middle Aged; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Time Factors; Treatment Outcome | 2020 |
1 other study(ies) available for atorvastatin and Infections, Coronavirus
| Article | Year |
|---|---|
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study.
Topics: Aged; Atorvastatin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Treatment Outcome | 2020 |